Rankings
▼
Calendar
TECX Q2 2023 Earnings — Tectonic Therapeutic, Inc. Revenue & Financial Results | Market Cap Arena
TECX
Tectonic Therapeutic, Inc.
$635M
Q2 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$11M
Net Income
-$10M
EPS (Diluted)
$18.29
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$259,000
Free Cash Flow
-$473,000
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$134M
Total Liabilities
$12M
Stockholders' Equity
$122M
Cash & Equivalents
$125M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
-$354,000
+100.0%
Operating Income
-$11M
-$28M
+61.7%
Net Income
-$10M
-$28M
+62.7%
← FY 2023
All Quarters
Q3 2023 →